The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen

Glycobiology

Volumn 20, Issue 2, 2009, Pages 138-147

  Brooks, Cory L ^a   Blackler, Ryan J ^a   Sixta, Georg ^b   Kosma, Paul ^b   Müller Loennies, Sven ^c   Brade, Lore ^c   Hirama, Tomoko ^d   MacKenzie, C Roger ^d   Brade, Helmut ^c   Evans, Stephen V ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c RESEARCH CENTER BORSTEL   (Germany)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Antibody structure; Chlamydia; Kdo; Protein carbohydrate interactions

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; 7 O METHYL 3 DEOXY MANNO OCTULOSONIC ACID; HISTONE H3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY S67-27; UNCLASSIFIED DRUG; 2-KETO-3-DEOXYOCTONATE; BACTERIAL ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; LIPOPOLYSACCHARIDE; SUGAR ACID;

ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; ANIMAL; ANTIGEN ANTIBODY REACTION; BAGG ALBINO MOUSE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; IMMUNOLOGY; MOUSE; SYNTHESIS;

BACTERIA (MICROORGANISMS); CHLAMYDIA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, BACTERIAL; COMPLEMENTARITY DETERMINING REGIONS; IMMUNOGLOBULIN HEAVY CHAINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SUGAR ACIDS;

EID: 77649203405     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp150     Document Type: Article

References (52)

1. Abhinandan KR, Martin ACR. 2008. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol Immunol. 45:3832-3839.
2. Adamczyk A, Moore JA, Yu Z. 2000. Application of surface plasmon resonance toward studies of low-molecular weight antigen-antibody binding interactions. Methods. 20:319-328.
3. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Read RJ, Sacchettini JC, Sauter NK, Terwilliger TC. 2002. PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr. 58:1948-1954.
4. Al-Lazikani B, Lesk AM, Chothia C. 1997. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol. 273:927-948.
5. Barrios Y, Jirholt P, Phlin M. 2004. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit. 17:332-338.
6. Brabetz W, Müller-Loennies S, Holst O, Brade H. 1997. Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. Eur J Biochem. 247(2):716-724.
7. Brade L, Gronow S,Wimmer N, Kosma P, Brade H. 2002. Monoclonal antibodies against D-glycero-(-D-talo-oct-2-ulosonic acid (Ko). J Endotoxin Res. 8:357-364.
8. Brade L, Rozalski A, Kosma P, Brade H. 2000. A monoclonal antibody recognizing the 3-deoxy-(-D-manno-oct-2-ulosonic acid (Kdo) trisaccharide (Kdo(2→4)(Kdo(2→4)(Kdo of Chlamydophila psittaci 6BC lipopolysaccharide. J Endotoxin Res. 6:361-368.
9. Brochet X, Lefranc MP, Giudicelli V. 2008. IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-DJ sequence analysis. Nucl Acids Res. 36:503-508.
10. Brooks CL, Müller-Loennies S, Borisove SN, Brade L, Kosma P, Hirama T, MacKenzie CR, Brade H, Evans SV. 2009. Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition. Biochemistry. submitted.
11. Brooks CL, Müller-Loennies S, Brade L, Kosma P, Hirama T, MacKenzie CR, Brade H, Evans SV. 2008. Exploration of specificity in germline monoclonal antibody recognition of a range of natural and synthetic epitopes. J Mol Biol. 377:450-468.
12. Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA. 2005. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci. 102:13372-13377.
13. Chothia C, Lesk AM. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. 196:901-917.
14. H segments. J Mol Biol. 227:799-817.
15. Cohen GH, Silverton EW, Padlan EA, Dyda F, Wibbenmeyer JA, Wilson RC, Davies DR. 2005. Water molecules in the antibody-antigen interface of the structure of the Fab HyHEL-5-lysozyme complex at 1.7 A resolution: Comparison with results from isothermal titration calorimetry. Acta Crystallogr. 61:628-633.
16. Cygler M, Rose DR, Bundle DR. 1991. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 253:442-445.
17. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D60:2126-2132.
18. Fleury D, Daniels RS, Skehel JJ, Knossow M, Bizebard T. 2000. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins. 40:572-578.
19. Fu Y, Baumann M, Kosma P, Brade L, Brade H. 1992. A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart. Infect Immun. 60:1314-1321.
20. Guarne A, Bravo J, Calvo J, Lozano F, Vives J, Fita I. 1996. Conformation of the hypervariable region L3 without the key proline residue. Protein Sci. 5:167-169.
21. Holst O, Broer W, Thomas-Oates JE, Mamat U, Brade H. 1993. Structural analysis of two oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant strain of Escherichia coli F515 (Re chemotype) expressing the genus-specific epitope of chlamydia lipopolysaccharide. Eur J Biochem. 214:703-710.
22. Hozumi N, Tonegawa S. 1976. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci. 73:3628-3632.
23. Isshiki Y, Kawahara K, Z̈ahringer U. 1998. Isolation and characterisation of disodium (4-amino-4-deoxy-beta-L-arabinopyranosyl)-(1→8)-(D-glyceroalpha-D-talo-oct-2-ulopyranosylona te)-(2→4)-(methyl 3-deoxy-D-mannooct-2-ulopyranosid)onate from the lipopolysaccharide of Burkholderia cepacia. Carbohydr Res. 313:21-27.
24. Jacob J, Kelsoe G, Rajewsky K, Weiss U. 1991. Intraclonal generation of antibody mutants in germinal centres. Nature. 354:389-392.
25. James LC, Roversi P, Tawfik DS. 2003. Antibody multispecificity mediated by conformational diversity. Science. 299:1362-1367.
26. Jeffrey PD, Bajorath J, Chang CY, Yelton D, Hellstr̈om I, Hellstr̈om KE, Sheriff S. 1995. The x-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol. 2:466-471.
27. Kabat EA, Wu TT, Bilofsky H, Reid-Miller M, Perry H. 1983. Sequence of Proteins of Immunological Interest. Bethesda, MD: National Institutes of Health.
28. Kawahara K, Brade H, Rietschel ET, Zringer U. 1987. Studies on the chemical structure of the core-lipid A region of the lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305. Detection of a new 2-octulosonic acid interlinking the core oligosaccharide and lipidAcomponent. Eur J Biochem. 163(3):489-495.
29. Kosma P, Schulz G, Unger FM, Brade H. 1989. Synthesis of trisaccharides containing 3-deoxy-D-manno-2-octulosonic acid residues related to the Kdo region of enterobacterial lipopolysaccharides. Carbohydr Res. 190:191-201.
30. L interface. Proteins. 75:139-146.
31. Landsteiner K. 1962. The Specificity of Serological Reactions. New York (NY): Dover Publications.
32. Manivel V, Shahoo NC, Salunke DM, Rao KVS. 2000. Maturation of an antibody response is governed by modulations in the flexibility of the antigen combining site. Immunity. 13:611-620.
33. Marchalonis JJ, Adelman MK, Robey IF, Schluter SF, Edmundson AB. 2001. Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans. J Mol Recognit. 14:110-21.
34. Martin AC, Thornton JM. 1996. Structural families of loops in homologous proteins: Automatic classification, modelling and application to antibodies. J Mol Biol. 263:800-815.
35. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr. 40:658-674.
36. A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae and Chlamydia trachomatis
37. Müller-Loennies S, MacKenzie CR, Patenaude SI, Evans SV, Kosma P, Brade H, Brade L, Narang S. 2000. Characterization of high affinity monoclonal antibodies specific for chlamydial lipopolysaccharide. Glycobiology. 10:121- 130.
38. Nguyen HP, Seto NO, MacKenzie CR, Brade L, Kosma P, Brade H, Evans SV. 2003. Germline antibody recognition of distinct carbohydrate epitopes. Nat Struct Biol. 10:1019-1025.
39. Peterson EM, De La Maza LM, Brade L, Brade H. 1998. Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae. Infect Immun. 66:3848-3855.
40. Pinilla C, Martin R, Gran B, Appel JR, Boggiano C,Wilson DB, Houghten RA. 1999. Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol. 11:193-202.
41. Ramsland PA, Farrugia W, Bradford TM, Mark Hogarth P, Scott AM. 2004. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumour antigens. J Mol Biol. 340:809-818.
42. Schnaitman CA, Klena JD. 1993. Genetics of lipopolysaccharide in enteric bacteria. Microbiol Rev. 57(3):655-682.
43. Sixta G, Wimmer K, Hofinger A, Brade H, Kosma P. 2009. Synthesis and antigenic properties of C-7-modified Kdo mono- and disaccharide ligands and Kdo disaccharide interresidue lactones. Carbohydr Res. 344:1660-1669.
44. κ domain. EMBO J. 14(18):4628-4638.
45. van Roon AM, Pannu NS, de Vrind JPM, van der Marel GA, van Boom JH, Hokke CH, Deelder AM, Abrahams JP. 2004. Structure of an anti-lewis X Fab fragment in complex with its lewis X antigen. Structure 12:1227-1236.
46. Vargas-Madrazo E, Paz-Garcia E. 2002. Modifications to canonical structure sequence patterns: Analysis for L1 and L3. Proteins. 47:250-254.
47. Villeneuve S, Souchob H, Riottot MM, Mazie JC, Lei P, Glaudemans CP,Kovac P, Fournier JM, Alzari PM. 2000. Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity. Proc Natl Acad Sci. 97:8433-8438.
48. Vyas NK, Vyas MC, Chervenak MC, Johnson MA, Pinto BM, Bundle DR, Quicho FA. 2002. Molecular recognition of oligosaccharide epitopes by a monoclonal Fab specific for Shigella flexneri Y lipopolysaccharide: X-ray structures and thermodynamics. Biochemistry. 41:13575-13586.
49. Wimmer N, Brade H, Kosma P. 2000. Synthesis of neoglycoproteins containing D-glycero-D-talo-oct-2-ulopyranosylonic acid (Ko) ligands corresponding to core units from Burkholderia and Acinetobacter lipopolysaccharide. Carbohydr Res. 392:549-556.
50. Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, et al. 2007. Polyspecificity of T cell and B cell receptor recognition. Semin Immunol. 19:216-224.
51. Xu JL, Davis MM. 2000. Diversity in the CDR3 region of VH is sufficient for most antibody specificities. Immunol. 13:37-45.
52. Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP. 2004. IMGT/JunctionAnalysis: The first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J junctions. Bioinformatics. 20:I379-I385.